Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-09-02

Clinical Trial Update: Level of HER2-neu Gene Amplification an Response to Trastuzumab

View source ↗

Summary

The document discusses a clinical trial investigating whether the level of HER2/neu gene amplification correlates with response to trastuzumab in advanced breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HERCEPTIN (trastuzumab)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Advanced Breast Cancer | Status: UNKNOWN